Fluorouracil 50mg/ml Inj, 50ml

Manufacturer FRESENIUS KABI Active Ingredient Fluorouracil (Systemic)(flure oh YOOR a sil) Pronunciation FLOOR-oh-YOOR-uh-sill
It is used to treat cancer.
🏷️
Drug Class
Antineoplastic Agent
🧬
Pharmacologic Class
Antimetabolite, Pyrimidine Analog
🤰
Pregnancy Category
Category D
FDA Approved
Jan 1962
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Fluorouracil is a chemotherapy drug used to treat various types of cancer. It works by interfering with the growth of cancer cells, which are fast-growing cells in your body. Because it affects fast-growing cells, it can also affect healthy cells, leading to side effects.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and follow all instructions provided. This medication is administered via injection into a vein, either as a single dose or continuously over a period of time.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

If you miss a dose, contact your doctor immediately to receive guidance on the next steps to take.
💡

Lifestyle & Tips

  • Report any signs of infection (fever, chills, sore throat) immediately.
  • Report severe diarrhea (more than 4-6 loose stools per day) or bloody stools immediately.
  • Report mouth sores, pain, or difficulty eating/drinking.
  • Report redness, swelling, pain, or blistering on hands or feet (hand-foot syndrome).
  • Avoid contact with people who are sick or have infections.
  • Practice good hand hygiene.
  • Avoid live vaccines during treatment.
  • Use effective contraception during and for a period after treatment (for both men and women).
  • Stay well-hydrated unless otherwise instructed by your doctor.
  • Avoid alcohol and tobacco.
  • Discuss any new medications, including over-the-counter drugs, supplements, or herbal remedies, with your doctor before taking them.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: Highly variable based on indication and regimen. Common regimens include: 1. Bolus: 12 mg/kg IV once daily for 4 days, then 6 mg/kg IV every other day. 2. Continuous Infusion: 1000 mg/m² IV over 24 hours for 4-5 days, repeated every 3-4 weeks. Often combined with leucovorin.
Dose Range: 370 - 1000 mg

Condition-Specific Dosing:

Colorectal Cancer (adjuvant): Often 400 mg/m² IV bolus on Day 1, then 2400 mg/m² IV continuous infusion over 46 hours, every 2 weeks (FOLFOX/FOLFIRI regimens).
Breast Cancer: Often 500-600 mg/m² IV on Day 1, every 3-4 weeks (CMF/AC regimens).
Gastric/Pancreatic Cancer: Often 400 mg/m² IV bolus on Day 1, then 2400 mg/m² IV continuous infusion over 46 hours, every 2 weeks (FOLFOX/FOLFIRI regimens).
Head and Neck Cancer: Often 1000 mg/m² IV continuous infusion over 24 hours for 4-5 days, repeated every 3-4 weeks.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established, but used off-label in some pediatric malignancies (e.g., solid tumors, brain tumors) with dose adjustments based on BSA and toxicity.
Adolescent: Not established, but used off-label in some pediatric malignancies with dose adjustments based on BSA and toxicity.
⚕️

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended.
Moderate: No specific dose adjustment recommended, but monitor for increased toxicity.
Severe: No specific dose adjustment recommended, but monitor for increased toxicity. Use with caution.
Dialysis: Fluorouracil is dialyzable. Administer after dialysis. Monitor for increased toxicity.

Hepatic Impairment:

Mild: No specific dose adjustment recommended.
Moderate: Use with caution. Consider dose reduction (e.g., 30-50%) in patients with significant hepatic dysfunction (e.g., bilirubin > 5 mg/dL or AST > 4x ULN) due to potential for increased toxicity. Monitor closely.
Severe: Use with extreme caution. Significant dose reduction (e.g., 50% or more) or avoidance may be necessary. Monitor closely for toxicity.

Pharmacology

🔬

Mechanism of Action

Fluorouracil (5-FU) is a pyrimidine analog antimetabolite. It acts by interfering with DNA and RNA synthesis. 5-FU is converted intracellularly to several active metabolites: 1. Fluorodeoxyuridine monophosphate (FdUMP), which inhibits thymidylate synthase (TS), thereby blocking the synthesis of thymidylate, a precursor of DNA. This leads to 'thymineless death' of rapidly dividing cells. 2. Fluorouridine triphosphate (FUTP), which is incorporated into RNA, leading to abnormal RNA synthesis and function. 3. Fluorodeoxyuridine triphosphate (FdUTP), which is incorporated into DNA, leading to DNA damage and fragmentation. The net effect is the disruption of nucleic acid synthesis and function, leading to cell death, particularly in rapidly proliferating cancer cells.
📊

Pharmacokinetics

Absorption:

Bioavailability: Poor and erratic orally (variable, ~30-80%), primarily administered intravenously.
Tmax: Not applicable for IV bolus/infusion (peak levels achieved rapidly).
FoodEffect: Not applicable for IV administration.

Distribution:

Vd: 0.12-0.22 L/kg (distributes into total body water, CSF, and tumor tissue).
ProteinBinding: <10% (low).
CnssPenetration: Yes (crosses blood-brain barrier, detectable in CSF).

Elimination:

HalfLife: 10-20 minutes (biphasic, with a rapid initial phase and a slower terminal phase).
Clearance: Variable, depends on DPD activity.
ExcretionRoute: Primarily metabolic degradation (>80-90%) to inactive metabolites (e.g., fluoro-beta-alanine, FBAL), which are renally excreted. A small percentage (5-20%) is excreted unchanged in urine.
Unchanged: 5-20% (renal).
⏱️

Pharmacodynamics

OnsetOfAction: Rapid (cellular uptake and metabolism begin immediately after administration).
PeakEffect: Not directly measurable as a single peak for antineoplastic effect; continuous exposure or repeated dosing is required for therapeutic effect.
DurationOfAction: Cellular effects persist as long as active metabolites are present and incorporated into nucleic acids. Clinical effects (e.g., myelosuppression) are delayed and prolonged due to cell cycle effects.

Safety & Warnings

⚠️

BLACK BOX WARNING

WARNING: FATAL TOXICITIES. Fluorouracil is associated with a high incidence of severe and potentially fatal toxicities, including myelosuppression, mucositis, diarrhea, and neurotoxicity. The risk of severe toxicity is significantly increased in patients with dihydropyrimidine dehydrogenase (DPD) deficiency. Patients should be carefully selected for therapy and monitored closely for signs of toxicity. Discontinue fluorouracil if severe toxicity occurs.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of nervous system problems, including:
+ Changes in mood or behavior
+ Confusion
+ Fever
+ Numbness or tingling in the hands or feet
+ Stiff neck
+ Sensitivity to bright lights
+ Severe muscle weakness
Signs of infection, such as:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or discolored sputum
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of bleeding, including:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Feeling extremely tired or weak
Chest pain or pressure
Shortness of breath, significant weight gain, or swelling in the arms or legs
Abnormal heartbeat
Dizziness or fainting
Changes in vision
Redness or irritation on the palms of the hands or soles of the feet
Balance problems
Excessive sleepiness
Uncontrolled eye movements
Headache

Administration Site Reactions

This medication may cause irritation at the injection site. If the medication leaks from the vein, it can also cause irritation around the affected area. Inform your nurse if you experience any redness, burning, pain, swelling, or fluid leakage at the injection site.

Other Possible Side Effects

Like all medications, this drug can cause side effects. However, many people may not experience any side effects or only minor ones. If you're concerned about any of the following side effects or if they persist, contact your doctor:

Diarrhea
Upset stomach or vomiting
Decreased appetite
Mouth irritation or mouth sores
Hair loss
Dry skin
Changes in nail condition

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever (100.4°F or 38°C or higher) or chills
  • Severe diarrhea (especially if bloody or persistent)
  • Severe mouth sores or difficulty swallowing
  • Unusual bleeding or bruising
  • Severe nausea or vomiting that prevents eating/drinking
  • Severe hand-foot syndrome (pain, blistering)
  • Chest pain, shortness of breath, or palpitations
  • Confusion, dizziness, or problems with balance/coordination
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Certain health conditions, including:
+ Poor nutrition
+ Infections
+ Bone marrow problems, such as:
- Low white blood cell count
- Low platelet count
- Low red blood cell count
If you have dihydropyrimidine dehydrogenase (DPD) deficiency
If you are breast-feeding. Note: You should not breast-feed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood work and laboratory tests, as directed by your doctor, are crucial to monitor your condition.

This medication can cause low blood cell counts, which may lead to bleeding problems, infections, or anemia. In severe cases, these conditions can be life-threatening. If you have any questions or concerns, discuss them with your doctor. You may be more susceptible to infections, so it is vital to practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.

Be cautious, as this medication can increase your risk of bleeding easily. To minimize this risk, use a soft toothbrush and an electric razor, and avoid injuries. If you experience stomach upset, vomiting, diarrhea, or loss of appetite, consult your doctor, as they may be able to suggest ways to alleviate these side effects. If you have diarrhea or vomiting, it is crucial to prevent dehydration and electrolyte imbalances; your doctor will provide guidance on how to manage these conditions.

Patients who lack the enzyme dihydropyrimidine dehydrogenase (DPD) are at a higher risk of severe and potentially life-threatening side effects, including mouth irritation or sores, diarrhea, low white blood cell counts, and nerve problems.

This medication may also increase the risk of heart problems, such as heart attack, heart failure, and abnormal heartbeat, particularly in individuals with a history of heart disease. Discuss your cardiovascular health with your doctor. Before receiving any vaccinations, consult your doctor, as some vaccines may not be effective or may increase the risk of infection when taken with this medication.

Additionally, this medication can increase your sensitivity to the sun, making you more prone to sunburn. Take necessary precautions when exposed to the sun, and inform your doctor if you experience excessive sunburn.

This medication may affect fertility, potentially leading to difficulties in becoming pregnant or fathering a child. If you plan to conceive, discuss your options with your doctor before starting treatment. Women who are pregnant or may become pregnant should not take this medication, as it can harm the unborn baby. If you or your partner may become pregnant, it is essential to use birth control during treatment and for a specified period after the last dose, as directed by your doctor. If you or your partner becomes pregnant, notify your doctor immediately.
🆘

Overdose Information

Overdose Symptoms:

  • Severe myelosuppression (very low white blood cell count, platelets)
  • Severe mucositis (mouth sores, inflammation of GI tract)
  • Severe diarrhea
  • Neurotoxicity (ataxia, confusion, seizures)
  • Cardiotoxicity (arrhythmias, angina, myocardial infarction)

What to Do:

Seek immediate medical attention. There is no specific antidote for fluorouracil overdose. Management is supportive, including aggressive hydration, antiemetics, antidiarrheals, antibiotics for neutropenic fever, and potentially uridine triacetate (Vistogard) if administered within 96 hours of overdose or early onset of severe toxicity.

Drug Interactions

🔴

Major Interactions

  • Brivudine, Sorivudine, and related antivirals (e.g., netivudine): Potent DPD inhibitors, leading to massive increase in 5-FU exposure and severe, potentially fatal toxicity (e.g., myelosuppression, mucositis, neurotoxicity). Concomitant use is absolutely contraindicated.
  • Live vaccines: Increased risk of severe or fatal infection due to immunosuppression.
🟡

Moderate Interactions

  • Leucovorin: Enhances the cytotoxic effects of 5-FU by stabilizing the binding of FdUMP to thymidylate synthase, leading to increased efficacy but also increased toxicity (e.g., myelosuppression, diarrhea, mucositis). Dose adjustments of 5-FU may be needed.
  • Allopurinol: May decrease the cytotoxic effects of 5-FU by inhibiting its metabolism, potentially reducing efficacy. Not routinely recommended for concurrent use.
  • Cimetidine, Metronidazole, Interferon alfa: May increase 5-FU plasma concentrations and toxicity.
  • Thiazide diuretics: May increase myelosuppression.
  • Warfarin: May enhance the anticoagulant effect of warfarin, increasing bleeding risk. Monitor INR closely.
  • Phenytoin: May decrease phenytoin levels.
  • Other myelosuppressive agents (e.g., other chemotherapies, radiation therapy): Additive myelosuppression.
🟢

Minor Interactions

  • Folic acid supplements: May theoretically interfere with 5-FU action, but clinical significance is generally low unless very high doses are used.

Monitoring

🔬

Baseline Monitoring

Complete Blood Count (CBC) with differential and platelets

Rationale: To establish baseline hematologic status and assess for pre-existing cytopenias before initiating myelosuppressive therapy.

Timing: Prior to first dose.

Liver Function Tests (LFTs) - AST, ALT, bilirubin, alkaline phosphatase

Rationale: To assess hepatic function, as 5-FU is primarily metabolized in the liver and hepatic impairment may increase toxicity.

Timing: Prior to first dose.

Renal Function Tests (RFTs) - Serum creatinine, BUN

Rationale: To assess renal function, as a small portion of 5-FU and its metabolites are renally excreted, and renal impairment may affect clearance of metabolites.

Timing: Prior to first dose.

DPD (Dihydropyrimidine Dehydrogenase) deficiency testing (optional, but recommended by some guidelines)

Rationale: To identify patients at high risk for severe, life-threatening toxicity (e.g., myelosuppression, neurotoxicity, mucositis) due to impaired 5-FU metabolism. Not universally performed, but increasingly considered.

Timing: Prior to first dose.

Electrolytes (Potassium, Magnesium, Calcium)

Rationale: To establish baseline and monitor for potential imbalances, especially with severe diarrhea.

Timing: Prior to first dose.

📊

Routine Monitoring

Complete Blood Count (CBC) with differential and platelets

Frequency: Prior to each cycle/dose, and at nadir (typically 7-14 days after bolus dose, or during/after continuous infusion).

Target: WBC > 3,500/mm³, ANC > 1,500/mm³, Platelets > 100,000/mm³ (general guidelines, may vary by protocol).

Action Threshold: Hold or reduce dose for significant myelosuppression (e.g., ANC < 1,500/mm³, platelets < 75,000-100,000/mm³).

Liver Function Tests (LFTs)

Frequency: Prior to each cycle/dose, or as clinically indicated.

Target: Within normal limits or stable.

Action Threshold: Significant elevation may warrant dose adjustment or delay.

Renal Function Tests (RFTs)

Frequency: Prior to each cycle/dose, or as clinically indicated.

Target: Within normal limits or stable.

Action Threshold: Significant impairment may warrant dose adjustment or delay.

Electrolytes

Frequency: As clinically indicated, especially with diarrhea or vomiting.

Target: Within normal limits.

Action Threshold: Correct imbalances promptly.

👁️

Symptom Monitoring

  • Diarrhea (frequency, severity, presence of blood)
  • Mucositis/Stomatitis (oral pain, redness, ulcers)
  • Nausea and vomiting
  • Hand-foot syndrome (palmar-plantar erythrodysesthesia - redness, swelling, pain, blistering of palms/soles)
  • Fatigue
  • Signs of infection (fever, chills, sore throat)
  • Bleeding/bruising (petechiae, epistaxis)
  • Neurological symptoms (ataxia, confusion, lethargy, headache)
  • Cardiac symptoms (chest pain, shortness of breath, palpitations)

Special Patient Groups

🤰

Pregnancy

Fluorouracil is classified as Pregnancy Category D. It can cause fetal harm when administered to a pregnant woman. It is a known teratogen and embryotoxic in animals. Avoid use during pregnancy. If used during pregnancy, the patient should be apprised of the potential hazard to the fetus.

Trimester-Specific Risks:

First Trimester: Highest risk of major congenital malformations and spontaneous abortion due to critical organogenesis.
Second Trimester: Risk of fetal growth restriction, myelosuppression, and other developmental abnormalities.
Third Trimester: Risk of fetal growth restriction, myelosuppression, and other developmental abnormalities. May also affect neonatal bone marrow.
🤱

Lactation

Lactation Risk Category L5 (Contraindicated). It is unknown if fluorouracil is excreted in human milk. Due to the potential for serious adverse reactions in the breastfed infant, breastfeeding is contraindicated during fluorouracil therapy and for a period after the last dose (e.g., at least 1 week, or as advised by a healthcare professional).

Infant Risk: High risk of serious adverse effects, including myelosuppression, growth inhibition, and other toxicities.
👶

Pediatric Use

Safety and efficacy have not been established in pediatric patients. However, fluorouracil is used off-label in various pediatric malignancies (e.g., solid tumors, brain tumors) based on adult data and clinical experience. Dosing is typically based on body surface area, and close monitoring for toxicity is essential. Pediatric patients may be more susceptible to certain toxicities.

👴

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Elderly patients may have reduced renal or hepatic function, or more comorbidities, requiring careful monitoring and potential dose adjustments. Increased risk of myelosuppression and other toxicities may be observed in the elderly.

Clinical Information

💎

Clinical Pearls

  • DPD deficiency: Patients with partial or complete DPD deficiency are at significantly increased risk of severe, life-threatening, or fatal toxicity. Consider DPD testing prior to initiation, especially if severe toxicity is anticipated or occurs early.
  • Leucovorin interaction: Leucovorin enhances 5-FU's activity and toxicity. Ensure correct dosing and administration sequence (leucovorin typically given before or concurrently with 5-FU).
  • Hand-foot syndrome (PPE): Common side effect. Advise patients on preventative measures (e.g., avoiding friction/heat, moisturizing) and early reporting. Pyridoxine (Vitamin B6) or topical emollients may help.
  • Cardiotoxicity: Although rare, 5-FU can cause cardiotoxicity (angina, MI, arrhythmias, cardiomyopathy), especially in patients with pre-existing cardiac disease. Monitor for cardiac symptoms.
  • Neurotoxicity: Rare but can occur (e.g., cerebellar ataxia, confusion, lethargy). More common with high-dose bolus regimens or DPD deficiency.
  • Diarrhea and Mucositis: These are dose-limiting toxicities. Aggressive management with antidiarrheals (e.g., loperamide) and oral hygiene/pain control is crucial. Severe cases may require hospitalization and IV fluids.
  • Extravasation: Fluorouracil is an irritant. Administer via a free-flowing IV line. If extravasation occurs, apply cold compresses and elevate the limb. Hyaluronidase may be considered.
🔄

Alternative Therapies

  • Other antimetabolites (e.g., Gemcitabine, Pemetrexed, Methotrexate)
  • Other cytotoxic agents (e.g., Oxaliplatin, Irinotecan, Paclitaxel)
  • Targeted therapies (e.g., Bevacizumab, Cetuximab, Panitumumab)
  • Immunotherapy (e.g., Pembrolizumab, Nivolumab)
💰

Cost & Coverage

Average Cost: $50 - $200 per 50ml vial (2500mg)
Generic Available: Yes
Insurance Coverage: Tier 4 (Specialty Drug) or Tier 2/3 (Generic Chemotherapy), depending on plan and indication.
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, avoid flushing medications down the toilet or pouring them down the drain. If you are unsure about the proper disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.